194 related articles for article (PubMed ID: 30619284)
21. Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3.
Wilson CL; Mann J; Walsh M; Perrugoria MJ; Oakley F; Wright MC; Brignole C; Di Paolo D; Perri P; Ponzoni M; Karin M; Mann DA
PLoS One; 2014; 9(1):e83391. PubMed ID: 24416163
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.
Isogawa M; Robek MD; Furuichi Y; Chisari FV
J Virol; 2005 Jun; 79(11):7269-72. PubMed ID: 15890966
[TBL] [Abstract][Full Text] [Related]
23. IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.
Liu MQ; Zhou DJ; Wang X; Zhou W; Ye L; Li JL; Wang YZ; Ho WZ
PLoS One; 2012; 7(4):e35902. PubMed ID: 22558263
[TBL] [Abstract][Full Text] [Related]
24. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
25. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
26. Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3.
Werner M; Schefczyk S; Trippler M; Treckmann JW; Baba HA; Gerken G; Schlaak JF; Broering R
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215812
[TBL] [Abstract][Full Text] [Related]
27. The TLR3/IRF1/Type III IFN Axis Facilitates Antiviral Responses against Enterovirus Infections in the Intestine.
Su R; Shereen MA; Zeng X; Liang Y; Li W; Ruan Z; Li Y; Liu W; Liu Y; Wu K; Luo Z; Wu J
mBio; 2020 Nov; 11(6):. PubMed ID: 33203755
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
29. Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication.
Tan G; Xiao Q; Song H; Ma F; Xu F; Peng D; Li N; Wang X; Niu J; Gao P; Qin FX; Cheng G
Cell Mol Immunol; 2018 Mar; 15(3):272-281. PubMed ID: 28194021
[TBL] [Abstract][Full Text] [Related]
30. Identification of
Tan G; Xu F; Song H; Yuan Y; Xiao Q; Ma F; Qin FX; Cheng G
Front Immunol; 2018; 9():1872. PubMed ID: 30150992
[TBL] [Abstract][Full Text] [Related]
31. Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.
Sasaki R; Kanda T; Nakamura M; Nakamoto S; Haga Y; Wu S; Shirasawa H; Yokosuka O
PLoS One; 2016; 11(1):e0146314. PubMed ID: 26731332
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes.
Zhang Z; Filzmayer C; Ni Y; Sültmann H; Mutz P; Hiet MS; Vondran FWR; Bartenschlager R; Urban S
J Hepatol; 2018 Jul; 69(1):25-35. PubMed ID: 29524530
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen.
Real CI; Lu M; Liu J; Huang X; Trippler M; Hossbach M; Deckert J; Jahn-Hofmann K; Ickenstein LM; John MJ; Gibbert K; Dittmer U; Vornlocher HP; Schirmbeck R; Gerken G; Schlaak JF; Broering R
Sci Rep; 2016 Apr; 6():24865. PubMed ID: 27121087
[TBL] [Abstract][Full Text] [Related]
34. Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells.
Imaizumi T; Yoshida H; Hayakari R; Xing F; Wang L; Matsumiya T; Tanji K; Kawaguchi S; Murakami M; Tanaka H
Neurosci Res; 2016 Apr; 105():35-41. PubMed ID: 26423178
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.
Bai L; Zhang W; Tan L; Yang H; Ge M; Zhu C; Zhang R; Cao Y; Chen J; Luo Z; Ho W; Liu F; Wu K; Wu J
J Mol Cell Biol; 2015 Dec; 7(6):543-56. PubMed ID: 26180054
[TBL] [Abstract][Full Text] [Related]
36. HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitro.
Bai Q; An J; Wu X; You H; Ma H; Liu T; Gao N; Jia J
Int J Mol Med; 2012 Dec; 30(6):1443-50. PubMed ID: 23042547
[TBL] [Abstract][Full Text] [Related]
37. An HBV-encoded miRNA activates innate immunity to restrict HBV replication.
Zhao X; Sun L; Mu T; Yi J; Ma C; Xie H; Liu M; Tang H
J Mol Cell Biol; 2020 May; 12(4):263-276. PubMed ID: 31865380
[TBL] [Abstract][Full Text] [Related]
38. TLRs antiviral effect on hepatitis B virus in HepG2 cells.
Xia C; Lu M; Zhang Z; Meng Z; Zhang Z; Shi C
J Appl Microbiol; 2008 Nov; 105(5):1720-7. PubMed ID: 19149768
[TBL] [Abstract][Full Text] [Related]
39. Targeted induction of interferon-λ in humanized chimeric mouse liver abrogates hepatotropic virus infection.
Nakagawa S; Hirata Y; Kameyama T; Tokunaga Y; Nishito Y; Hirabayashi K; Yano J; Ochiya T; Tateno C; Tanaka Y; Mizokami M; Tsukiyama-Kohara K; Inoue K; Yoshiba M; Takaoka A; Kohara M
PLoS One; 2013; 8(3):e59611. PubMed ID: 23555725
[TBL] [Abstract][Full Text] [Related]
40. Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV-relative liver cirrhosis.
Wei X; Qian J; Yao W; Chen L; Guan H; Chen Y; Xie Y; Lu H; Zhang Z; Shi L; Lin X
Scand J Immunol; 2019 Aug; 90(2):e12775. PubMed ID: 31069827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
